Accessibility Menu
Monash IVF Group logo

Monash IVF Group(ASX) MVF

Market CapA$270.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-36%
5 Year-12%
1 Year-11%
1 Month-1%
A$0.70
+0.72%
+0.00Today
Monash IVF Group last closing stock price
MetricPriceDate
Last closeAUD 0.702026-08-13
Monash IVF Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.702026-08-06
1 month-0.71%AUD 0.712026-07-14
3 month-4.11%AUD 0.732026-05-15
Year to date-3.04%AUD 0.722025-12-31
1 year-11.47%AUD 0.792025-08-13
3 year-34.69%AUD 1.072023-08-14
5 year-12.13%AUD 0.802021-08-13
Since inception-36.48%AUD 1.092014-06-26

Monash IVF Group Financials at a Glance

Market Cap

A$270.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$539.30M

Net Income (TTM)

A$12.87M

EPS (TTM)

A$0.04

P/E Ratio

17.87

Dividend

A$0.01

Beta (Volatility)

0.07 (Low)

Price

A$0.70

Volume

66,439

Open

A$0.70

Previous Close

A$0.70

Daily Range

A$0.70 - A$0.70

52-Week Range

A$0.58 - A$0.90

Estimated Earnings Date

Aug 24, 2026

MVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Monash IVF Group

Monash IVF Group Limited is a leading provider of specialized reproductive assistance and women's imaging services, operating across Australia and Malaysia. Founded in 2014 and headquartered in Richmond, Australia, the company offers a comprehensive range of fertility treatments, diagnostic obstetric and gynecological ultrasound examinations, and advanced prenatal diagnostics.

Products and Services
  • In-vitro fertilization (IVF) services
  • Diagnostic obstetric and gynecological ultrasound examinations
  • Advanced tertiary-level prenatal diagnostics
Growth Outlook
  • Strong demand for fertility services is expected to drive revenue growth
  • Expansion into new markets in Southeast Asia presents significant opportunities
  • Investment in technology and facilities enhances service offerings and efficiency
Financial Highlights
  • Recent quarterly revenue of AUD 137.86 million, up from AUD 131.53 million
  • Net income for the latest quarter reached AUD 7.16 million
  • Trailing twelve months (TTM) revenue of AUD 537.5 million reflects consistent growth
Monash IVF Group Limited has established itself as a key player in the healthcare sector, particularly in reproductive health. The company's focus on innovation and quality care positions it well for future growth. Recent financial performance indicates a positive trajectory, with increasing revenues and net income, suggesting effective management and operational efficiency. The ongoing demand for fertility services, coupled with strategic expansion plans, underscores the potential for sustained growth in the coming years. Investors may find Monash IVF Group Limited an intriguing opportunity within the healthcare industry.
AI Generated • Jul 17, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

892

CEO

Malik Jainudeen

Website

www.monashivfgroup.com.au

Headquarters

Richmond, VIC 3121, AU

MVF Financials

Key Financial Metrics (TTM)

Gross Margin

28.17%

Operating Margin

11.33%

Net Income Margin

5.63%

Return on Equity

6.06%

Return on Capital

10.18%

Return on Assets

2.97%

Earnings Yield

5.60%

Dividend Yield

1.73%

Payout Ratio

66.83%

Stock Overview

Market Cap

A$270.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

389.63M

Volume

66.44K

Avg. Volume

529.64K

Financials (TTM)

Gross Profit

A$165.70M

Operating Income

A$32.42M

EBITDA

A$74.38M

Operating Cash Flow

A$52.66M

Capital Expenditure

-A$30.33M

Free Cash Flow

A$22.34M

Cash & ST Invst.

A$8.15M

Total Debt

A$281.81M

Monash IVF Group Performance Analysis

Monash IVF Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 192,294,000N/A
20232023-06-30AUD 213,590,00011.1%
20242024-06-30AUD 254,960,00019.4%
20252025-06-30AUD 271,917,0006.7%
Monash IVF Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-303.0%
Q22024-12-318.4%
Q42025-06-30-6.3%
Q22025-12-314.8%
Monash IVF Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD 0.05N/A
20232023-06-30AUD 0.0618.3%
20242024-06-30AUD -0.02N/A
20252025-06-30AUD 0.06N/A
Monash IVF Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-252.3%
Q22024-12-31187.5%
Q42025-06-30-52.7%
Q22025-12-31-10.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$137.86M

+9.7%

Gross Profit

A$33.34M

-11.9%

Gross Margin

24.19%

N/A

Market Cap

A$270.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$303.58K

N/A

Employees

892

N/A

Net Income

A$7.16M

-43.9%

EBITDA

A$27.05M

-9.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$8.15M

+37.4%

Total Debt

A$281.81M

+131.5%

Accounts Receivable

A$25.46M

+26.4%

Inventory

A$10.36M

+57.7%

Long Term Debt

A$270.85M

+276.1%

Short Term Debt

A$10.97M

-78.0%

Return on Assets

2.97%

N/A

Return on Invested Capital

6.69%

N/A

Free Cash Flow

A$3.14M

-73.3%

Operating Cash Flow

A$13.13M

-46.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PEB.AXPacific Edge Limited
A$0.22+0.00%
OCC.AXOrthocell Limited
A$0.79-0.63%
ARX.AXAroa Biosurgery Limited
A$0.59+0.85%
TTX.AXTetratherix Ltd.
A$6.50-8.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About MVF

What is the current price of Monash IVF Group?

Monash IVF Group is trading at A$0.70 per share.

What is the 52-week range for Monash IVF Group?

Over the past 52 weeks, Monash IVF Group has traded between A$0.58 and A$0.90.

How much debt does Monash IVF Group have?

As of the most recent reporting period, Monash IVF Group reported total debt of A$180.03M.

How much cash does Monash IVF Group have on hand?

Monash IVF Group reported A$9.43M in cash and cash equivalents in its most recent financial results.

What is Monash IVF Group’s dividend yield?

Monash IVF Group currently has a dividend yield of 1.73%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services